Company Performance: Novo Nordisk's financial health, including revenue, profit margins, and debt levels, significantly impacts its stock price.

Pharmaceutical Pipeline: Progress in developing and launching new drugs, especially in areas like diabetes and obesity, influences investor confidence.

Regulatory Approvals: Approvals or rejections of new drugs by regulatory bodies like the EMA and FDA directly affect future revenue potential.

Market Sentiment: Overall investor mood towards the pharmaceutical sector and Novo Nordisk, driven by news and macroeconomic conditions.

Competition: The performance and strategies of competitors in the diabetes and obesity markets affect Novo Nordisk's market share and perceived value.

Economic Conditions: Global economic factors like interest rates, inflation, and economic growth can influence investor decisions and stock valuations.

Currency Exchange Rates: Fluctuations in the Euro (EUR) against other currencies, particularly the Danish Krone (DKK) and US Dollar (USD), impact earnings as Novo Nordisk operates globally.

Analyst Ratings: Recommendations from financial analysts can influence investor behavior and stock price movements.

Dividend Policy: Changes in Novo Nordisk's dividend payout ratio affect investor appeal and stock value.

Geopolitical Events: Global events and political instability can introduce uncertainty and affect stock prices.

XETRA Index Movements: The overall performance of the XETRA DAX index, as NF4 is part of it, can influence its trading activity.